In This Store
Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Risdiplam
CAS No.:1825352-65-5
Standard:EP
Price(USD):Negotiable
Company:Polpharma
Grade: Pharmaceutical Grade
Factory Location: EU-Poland
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: yes
Payment Terms: L/C
Risdiplam
Status | Pipeline |
Development phase | Initial stage |
Therapeutic cat. | Musculo-skeletal |
CAS No. | 1825352-65-5 |
OEB No. |
4 |
Drug description
Risdiplam is an oral mRNA splicing modifier used in the treatment of spinal muscular atrophy (SMA).
Disclaimer: Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094
Follow Us: